Akums Drugs to raise ₹1,857 cr at price band of ₹646-679 a share; IPO to open on July 30
The IPO of Akums Drugs and Pharmaceuticals is a combination of fresh equities worth ₹680 crore and OFS of 1.73 crore shares worth ₹1,177 crore.
sebi
July 2024
7 out of 10 intraday traders in equity segment make losses: SEBI
SEBI says there has been a surge of over 300% in those participating in intraday trading in the equity cash segment in FY2022-23 compared to FY2018-19
SEBI to introduce 'new asset class' for high-risk-seeker investors
To deter retail investors, SEBI has placed a minimum investment limit of Rs.10 lakh, across one or more investment strategies, under the new asset class offered by an AMC/MF
Paytm receives SEBI warning over unapproved transactions
“The excess related party transactions entered into by the company with PPBL during the FY 2021-22 is without due approval of either the audit committee or the shareholders,” read the SEBI letter.
SAT to Religare: Comply with SEBI order, apply for open offer by Burmans
Religare exempted from any coercive action till August 29, 2024; SEBI to file response in one month
Akums Drugs, Gold Plus Glass, Ceigall, Orient Tech get SEBI nod to launch IPO
All these four companies filed their DRHP with the SEBI in February this year, while observations came between June 29 and July 2, 2024.
Reddit India forum dreams of infamous stock manipulator GameStop
Forum looks at the possibility to corner micro, small cap stocks with low float
Banking On Asset Quality
Even as the regulator is blowing hot, the flagbearers of Indian banking continue to hold sway over Fortune India-Grant Thornton Bharat’s 2024 ranking.
SEBI mandates surveillance of trading activities by stock brokers to prevent frauds
Sebi says this circular will protect investors' interests in securities and promote the development of the securities market
Zerodha may discontinue zero brokerage due to SEBI circular: CEO Nikhil Kamath
The market regulator in its new circular mandated all market infrastructure institutions, like stock exchanges, to be "true to the label" in how charges are levied.
